The mechanism of action of the C3b inactivator (conglutinogen- activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)
Open Access
- 1 May 1975
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 141 (5), 1221-1226
- https://doi.org/10.1084/jem.141.5.1221
Abstract
The fixation of the third component of complement (C3) results in many important biological phenomenon, among which are (a) immune adherence (1), (b) enhancement of phagocytosis (2,3), (c) the release of an anaphylatoxin which is a potent releaser of histamine (4), and (d) the feedback activation of the alternative pathway (5,6). The physiological mechanisms involving C3 fixation require the generation of a C3 convertase which may occur by two separate pathways. C3 convertase can be generated, in the form of C42, by the so-called classical pathway of activation or in the form C3b,B by the alternative or properdin pathway (7). In both cases, C3 is converted to C3b by cleavage of a small peptide, C3a. Normal human serum contains an inactivator of activated C3b. This C2b inactivator or conglutinogen-activating factor (KAF) has been shown to inhibit both immune hemolysis and the immune adherence properties of C3b and to cause cleavage of C3b in the fixed and fluid- phase stages (8-11).Keywords
This publication has 15 references indexed in Scilit:
- The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.1973
- Further studies on the C3b inactivator or conglutinogen activating factor (KAF)Immunochemistry, 1973
- Inactivator of the Third Component of Complement as an Inhibitor in the Properdin PathwayProceedings of the National Academy of Sciences, 1972
- C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTIONThe Journal of Experimental Medicine, 1972
- C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.1971
- Deficiency of C3 Inactivator in ManThe Journal of Immunology, 1971
- Two Anticomplementary Factors in Cobra Venom: Hemolysis of Guinea Pig Erythrocytes by One of ThemThe Journal of Immunology, 1969
- THE ENHANCEMENT OF BACTERIAL PHAGOCYTOSIS BY SERUMThe Journal of Experimental Medicine, 1969
- Anaphylatoxin Formation by Purified Human C′1 EsteraseThe Journal of Immunology, 1965
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965